ABU DHABI/WAM M42, a global health leader powered by technology, artificial intelligence and genomics, will ...
Read More »Moderna to push backup experimental flu shot after setback
BLOOMBERG Moderna Inc said a final-stage study of its first experimental flu shot hasn’t accumulated enough data to determine efficacy, and the company will advance another candidate. Moderna tested its messenger RNA flu shot against a traditional vaccine in a trial of about 23,000 people age 50 and older in the northern hemisphere. An independent panel of scientific advisers recommended ...
Read More »